Cramer's 'Mad Money' Recap: Citigroup Should Split

Plus, Colgate is a "leaner, meaner" company than PG and has "been more selective about its acquisitions," Cramer said. Colgate has restructured itself and is cutting costs. In addition, it is funding its own growth and innovating itself, he said.

Additionally, Cramer believes that Colgate could pick up some of PG's market share "as the lumbering giant tries to get into gear" and that it should now benefit from the "China Syndrome."

"Brush your portfolio up with Colgate," he advised.

In his "Mad Mail" segment, Cramer told a mailer to book gains and sell aQuantive (AQNT) now that the digital marketing company has been taken over.

Moreover, Cramer told another viewer that Raser Technologies (RZ) is too speculative for him. Instead, he suggested Corning (GLW), which Cramer owns for his charitable trust, Action Alerts PLUS.

During his "Sudden Death" round, Cramer was bullish on Haynes International (HAYN), Merit Medical Systems (MMSI), Cepheid (CPHD) and Dynegy (DYN).

Lightning Round

Cramer was bullish on Penwest Pharmaceuticals (PPCO), Gildan Activewear (GIL), GOL Linhas Areas Inteligentes (GOL), Chesapeake Energy (CHK), Fannie Mae (FNM), Celgene (CELG), Gilead Sciences (GILD), Fuel Tech (FTEK), Herbalife (HLF), Crocs (CROX), Genesis Lease (GLS), Boeing (BA), Tesco (TESO), Halliburton (HAL), Input/Output (IO), Trinity Industries (TRN) and Marathon Oil (MRO).

Cramer was bearish on AirTran Holdings (AAI), Mylan Laboratories (MYL), Usana Health Sciences (USNA) and JetBlue Airways (JBLU).

For more of Cramer's insights during the Lightning Round, click here.

---

Pop Quiz! Are you a loyal "Mad Money" viewer? Take TheStreet.com's new "Mad Money" culture quiz to see how much of the show you've caught this week or just to immerse yourself in Cramer's nonfinancial madness.

Want more Cramer? Check out Jim's rules and commandments for investing from his popular book by clicking here.

>To order reprints of this article, click here: Reprints